Task: Answer the multiple choice question.
Query: Which drug exhibits a -16.614% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) O=[N+]([O-])c1ccccc1/C=C/C=N/Nc1nc(N2CCCCC2)nc(N2CCCCC2)n1
b.) NC(=O)c1ccc([N+](=O)[O-])cc1SCc1ccccc1
c.) c1cncc(-c2nc(NCc3ccc4c(c3)OCO4)c3ccccc3n2)c1
Answer: c. c1cncc(-c2nc(NCc3ccc4c(c3)OCO4)c3ccccc3n2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1cncc(-c2nc(NCc3ccc4c(c3)OCO4)c3ccccc3n2)c1
c1cncc(-c2nc(NCc3ccc4c(c3)OCO4)c3ccccc3n2)c1
N-(1,3-benzodioxol-5-ylmethyl)-2-pyridin-3-ylquinazolin-4-amine